tiprankstipranks
Advertisement
Advertisement

HUMA Stock Latest News

Humacyte Earns Buy Rating as Phase 3 V007 Data Publication Strengthens Regulatory and Commercial Outlook
RatingsHumacyte Earns Buy Rating as Phase 3 V007 Data Publication Strengthens Regulatory and Commercial Outlook
7h ago
HUMA
Humacyte publishes V007 results in The Lancet Digital Health
PremiumThe Fly
Humacyte publishes V007 results in The Lancet Digital Health
14h ago
HUMA
Humacyte reports Q2 EPS (16c), consensus (10c)
PremiumThe Fly
Humacyte reports Q2 EPS (16c), consensus (10c)
3d ago
HUMA
Humacyte price target lowered to $1 from $2 at Benchmark
PremiumThe Fly
Humacyte price target lowered to $1 from $2 at Benchmark
3d ago
HUMA
Humacyte Faces Nasdaq Non-Compliance Warning as Share Price Risks Delisting and Future Capital Constraints
PremiumCompany Announcements
Humacyte Faces Nasdaq Non-Compliance Warning as Share Price Risks Delisting and Future Capital Constraints
6d ago
HUMA
Humacyte’s Symvess Trauma Study: Real-World Data Push With Investor Upside
PremiumCompany AnnouncementsHumacyte’s Symvess Trauma Study: Real-World Data Push With Investor Upside
6d ago
HUMA
Analyst Reiterates Buy on Humacyte, Maintains $4 Price Target Amid Dialysis Growth and Regulatory Catalysts
Premium
Ratings
Analyst Reiterates Buy on Humacyte, Maintains $4 Price Target Amid Dialysis Growth and Regulatory Catalysts
7d ago
HUMA
HUMA Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
HUMA Upcoming Earnings Report: What to Expect?
10d ago
HUMA
Humacyte Receives Nasdaq Notice on Bid Price Noncompliance
PremiumCompany Announcements
Humacyte Receives Nasdaq Notice on Bid Price Noncompliance
19d ago
8K
HUMA
Buy Rating Reaffirmed on Humacyte as FDA Clears First-in-Human CABG Study; $2 Price Target Maintained
PremiumRatings
Buy Rating Reaffirmed on Humacyte as FDA Clears First-in-Human CABG Study; $2 Price Target Maintained
22d ago
HUMA
Humacyte announces FDA acceptance of CTEV IND application
PremiumThe Fly
Humacyte announces FDA acceptance of CTEV IND application
24d ago
HUMA
Humacyte price target lowered to $1.25 from $1.50 at TD Cowen
PremiumThe Fly
Humacyte price target lowered to $1.25 from $1.50 at TD Cowen
2M ago
HUMA
Humacyte Announces Underwritten Public Equity Offering to Fund Growth
PremiumCompany AnnouncementsHumacyte Announces Underwritten Public Equity Offering to Fund Growth
2M ago
8K
HUMA
Humacyte price target raised to $4 from $3 at H.C. Wainwright
Premium
The Fly
Humacyte price target raised to $4 from $3 at H.C. Wainwright
2M ago
HUMA
Humacyte 47.62M share Spot Secondary priced at $1.05
Premium
The Fly
Humacyte 47.62M share Spot Secondary priced at $1.05
2M ago
HUMA
Humacyte TBA Spot Secondary; price range $1.05-$1.15
PremiumThe Fly
Humacyte TBA Spot Secondary; price range $1.05-$1.15
2M ago
HUMA
Humacyte Announces Positive Phase 3 Dialysis Access Results
PremiumCompany Announcements
Humacyte Announces Positive Phase 3 Dialysis Access Results
2M ago
8K
HUMA
Humacyte announces V012 study of ATEV meets primary endpoint
PremiumThe Fly
Humacyte announces V012 study of ATEV meets primary endpoint
2M ago
HUMA
Humacyte announces common stock offering, no amount given
PremiumThe Fly
Humacyte announces common stock offering, no amount given
2M ago
HUMA
Humacyte Shareholders Approve Governance Changes and Share Increase
PremiumCompany AnnouncementsHumacyte Shareholders Approve Governance Changes and Share Increase
2M ago
8K
HUMA
Humacyte Regains Nasdaq Compliance With Minimum Bid Price
Premium
Company Announcements
Humacyte Regains Nasdaq Compliance With Minimum Bid Price
3M ago
8K
HUMA
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
3M ago
TZA
YSS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >